Brings deep industry experience to the leading pharmaceutical data analytics firm focused on providing everyone with greater access to affordable medications
NEW YORK, NY—March 20, 2018—Truveris, Inc. today announced that Sally Welborn, the former senior vice president of global benefits at Walmart, was elected to the Truveris board of directors. Welborn is an innovative thought leader in total rewards with more than 30 years of wide-ranging industry experience and a significant national network of influential executives.
Truveris believes that everyone should have access to affordable medication. The company combines its deep domain expertise with big data analytics to deliver prescription drug affordability and access solutions for plan sponsors, members and other stakeholders. The company currently works with more than 400 pharmacy benefit plan sponsors as well as almost 40 pharmaceutical brands.
“Sally’s deep understanding of the challenges organizations face providing employee benefits will be a huge asset to Truveris,” said Faisal Mushtaq, Truveris CEO. “Throughout her career, Sally has demonstrated that she is a strategic thinker with a record of success in implementing ground-breaking initiatives. She is a highly respected healthcare policy expert, and we look forward to benefitting from her experience as we work to provide greater access to affordable medications so that everyone can live healthier lives.”
“Prescription drug affordability and accessibility is one of the most important issues in the US today,” said Ms. Welborn. “Truveris has unique capabilities to make a difference for payers and patients and I am honored to join its Board.”
Prior to founding Welborn Advisory Services, Welborn was Senior Vice President of Global Benefits at Walmart for nearly eight years. Prior to Walmart, she was Senior Vice President of Benefits at Wells Fargo for more than 11 years. Welborn serves as a Board Advisor for the Penn Center for Health Incentives and Behavioral Economics. She also currently serves on the Board of the Leapfrog Group and previously served on the board of the National Business Group on Health, as the Chair of the ERISA Industry Committee and as Vice Chair of the Pacific Business Group on Health.
Truveris brings transparency to the prescription drug ecosystem through data-driven innovations. Truveris’ platform offers customers – from the individual patient to employers, retailers, pharmacy benefits stakeholders, and manufacturers – the data and insights they need to effectively and efficiently manage rising costs and market access challenges. Visit www.truveris.com to learn more.
Jeff Ignaszak, Truveris, Inc., firstname.lastname@example.org